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A survey on the effect of oral vitamin C supplementation in patients 
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BACKGROUND: The positive effects of antioxidants in preventing atrial fibrillation (AF) after cardiac surgery and 
their low side effects have been proven. The aim of this study was to evaluate the effect of oral vitamin C 
supplementation on preventing post-operative AF in patients undergoing coronary artery bypass graft (CABG) 
surgery. Vitamin C was given orally to the patients three days before surgery for up to 5 days after surgery. This 
time difference was based on previous studies and cardiologist’s order. 
METHODS: In this study, patients who underwent CABG surgery, were divided into two groups. The first group (30 
patients), as the intervention group, received oral vitamin C supplementation, and the second group (30 patients), 
as the control group, did not receive vitamin C supplementation. All patients, during the post-operative period, 
underwent cardiac monitoring in cardiac intensive care unit (CICU). The inclusion criteria were: being over 50 years 
old, undergoing cardiac surgery only and no other kinds of surgery, undergoing coronary artery bypass surgery for 
the first time, and no cardio-respiratory arrest during or after surgery. Data were collected by convenience sampling 
method and were analyzed using SPSS software. 
RESULTS: The results of this study showed that 7 patients in the control group experienced post-operative AF, while 
3 patients in intervention group had the same experience. According to the results, the risk of AF in the 
intervention and control group was, respectively, 10.0% and 23.3%. Vitamin C significantly decreased the risk of AF 
after CABG surgery by 2 times. 
CONCLUSION: According to the results, oral vitamin C supplementation affected the incidence of AF after CABG 
surgery. Therefore, oral intake of vitamin C supplementation before and after surgery reduces the incidence of AF. 
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Introduction1 
Atrial fibrillation (AF) is the most common 
post cardiac operation dysrhythmia after sinus 
tachycardia.1 It is estimated that around 800000 
open heart surgery will be performed annually 
in the United States (US).2 The incidence of AF 
after cardiac surgery is higher in the elderly 
patients than others, and at the ages above 40, 
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for every ten years of age, the risk of 
arrhythmias increases by 50%.3 This 
arrhythmia is an independent risk factor for 
increasing the mortality rate with a risk ratio of 
1.5 for men and 1.9 for women.4 
Generally, AF is the most important cause 
of increasing complications and mortality after 
cardiac surgery.5 In addition, AF after cardiac 
surgery increases the average length of stay of 
patients in post-surgical intensive care units 
(ICUs), as well as the overall length of stay in 
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Many studies have shown the association 
between AF and the oxidative process of the 
heart muscle,7 which ultimately results in 
remodeling of the heart atrium (which is the 
basis of the pathophysiology of AF).8 Autopsy 
studies have shown inflammatory evidence 
such as myocyte necrosis and fibrosis in 
samples taken from the atrium tissue of 
patients with AF, while there was no 
inflammatory evidence in biopsy sample of 
patients without this dysrhythmia.9 
This evidence suggests a relationship 
between inflammatory process and AF.10 
Oxidative stress is inevitably present in 
patients undergoing cardiac surgery, and the 
presence of this inflammatory evidence in 
these patients is a great sign for predicting 
AF.11 The strengthening of the antioxidant 
defense system of the heart muscle seems to be 
a good way to protect the damage caused by 
oxidative stress.12 Ascorbic acid (vitamin C), as 
a potent antioxidant, probably prevents 
oxidative stress in these patients.13 
Studies have shown that the level of vitamin 
C decreases rapidly after fast peacemaking 
process in atrium.14 Vitamin C supplementation 
results in blockage of electrical impedance due 
to short-term and fast peacemaking process in 
atrium. The beneficial effect of vitamin C 
supplementation is on preventing the reduction 
of the level of ascorbic acid in the cell, which 
also reduces the proxynitrite, which is a 
mediator associated with AF.4 
Vitamin C, as an antioxidant, also reduces 
C-reactive protein (CRP) levels that shows the 
important role of vitamin C in reducing 
inflammation and its high anti-inflammatory 
effect.15 Therefore, there is an urgent need to 
achieve a way for preventing AF to reduce this 
huge burden of health system. Prophylactic 
strategies for AF are predictable in many cases, 
but these methods are currently inadequate 
and there is an urgent need for more effective 
and alternative methods to prevent AF rhythm 
in susceptible patients.16 
According to positive effects of antioxidants 
in preventing AF after cardiac surgery and 
their low side effects, it seems that the use of 
vitamin C supplementation, as a prophylactic 
strategy, in patients who undergo heart 
surgery is useful and effective, but more 
studies are still needed to ensure the 
effectiveness and impact of the drug and its 
possible side effects. 
Materials and Methods 
This interventional study was conducted in 
2016 for one year. The population included 
were patients undergoing coronary artery 
bypass graft (CABG) surgery in cardiovascular 
specialty and subspecialty center of Tohid 
Hospital in Sanandaj, Iran. The inclusion 
criteria were: being over 50 years old, 
undergoing cardiac surgery only and no other 
kinds of surgery, undergoing coronary artery 
bypass surgery for the first time, and no 
cardio-respiratory arrest during or after 
surgery. Exclusion criteria were: history of 
dysrhythmia, AF, having antiarrhythmic 
medication such as digoxin, history of 
pacemaker insertion, and chronic diseases.  
Data were collected by convenience 
sampling method, randomly, in such a way that 
all patients who were admitted to Tohid 
Hospital for elective CABG surgery were 
enrolled in the study if they had inclusion 
criteria and did not have exclusion criteria, and 
they were divided into intervention and control 
groups. Considering the intervention and the 
possibility of operating time for each group,  
30 samples were taken as a total of 60 samples. 
It was an interventional study in which oral 
vitamin C supplementation was prescribed to 
patients undergoing cardiac surgery and its 
effect on the incidence of AF was measured. 
Those who did not have inclusion criteria were 
excluded from the study. Patients were 
randomly divided into two groups. 12-lead 
electrocardiogram (ECG) was taken from all the 
patients who were admitted and their heart 
rhythm and ECG profile were recorded. Oral 
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tablet, Iran Darou Pharmaceutical Co., Iran) was 
given to the patients three days prior to surgery, 
up to 5 days after the operation, at a dose of 500 
mg twice a day. All of the patients went under 
CABG surgery by one team with one surgical 
procedure, standardly, with cardiopulmonary 
bypass (CPB) system. Also, all patients' standard 
drug requirements continued during 
hospitalization. The overall patient's attachment 
time to the CPB system from the insertion of the 
aortic clamp until the stabilizing heart re-
perfusion was recorded. After the operation and 
transferring the patient to the ICU, the patient's 
vital signs and hemodynamic status were 
recorded. Patients were under continuous 
cardiac monitoring during the entire period of 
hospitalization in the ICU and were monitored 
directly by the researcher throughout all this 
time. After transferring to the unit, they were 
monitored for three days by Holter monitoring 
and were analyzed by the relevant specialist. 
Data were analyzed using SPSS software 
(version 24, IBM Corporation, Armonk, NY, 
USA) by t-test and chi-square test.  
Results 
This clinical trial research was conducted  
on 60 patients who underwent surgical 
treatment in Tohid Hospital of Sanadaj in 
order to investigate the effect of vitamin C 
supplementation on AF after CABG surgery. 
The results showed a significant statistical 
difference between variables mentioned in the 
control and intervention groups and indicated 
that there was no significant statistical 
difference in the quantitative indexes of 
patients in the two groups. Moreover, the 
results showed that the probability of the effect 
of the quantitative indexes in post-operative 
AF was similar in the two groups and in the 
cases where there was a possibility of 
interference with other effective factors and the 
underlying and confounding factors on AF 
after the cardiac operation, the effect of the two 
groups was similar (Table 1). 
The results showed that both control and 
intervention groups were completely similar in 
terms of clinical features and demographic 
characteristics. The last column of table 2 
reflects the results of the chi-square test on the 
probability of a significant statistical difference 
between the variables mentioned in the control 
and intervention groups. The results indicated 
that there was no statistically significant 
difference between the qualitative variables 
studied in patients and the possibility of their 
effect on AF after cardiac surgery. The results 
also showed that both control and intervention 
groups in terms of clinical and paraclinical 
characteristics, during the operation of the heart 
surgery, were completely similar and the effect 
of these variables on the incidence of post-
operative AF was similar in both of the groups.  
 
Table 1. Comparison of quantitative statistical indices relative to demographic and  
paraclinical characteristics of patients in two groups of control and intervention 
Variable Control group Intervention group t P 
Mean ± SD Mean ± SD 
Age (year) 61.70 ± 7.30 60.07 ± 6.01 0.811 0.421 
LVEF (%) 43.30 ± 8.54 44.50 ± 7.80 0.632 0.243 
LVESD (cm) 2.88 ± 0.57 2.94 ± 0.59 -0.368 0.715 
LVEDD (cm) 4.61 ± 0.83 4.26 ± 0.61 1.810 0.075 
LAD (cm) 18.40 ± 2.48 19.30 ± 2.39 -1.320 0.191 
ESR (mm/h) (before surgery) 7.34 ± 6.05 7.34 ± 6.02 1.220 0.213 
WBC (×10
3
) (before surgery) 0.27 ± 0.44 0.27 ± 0.44 0.630 0.314 
Hb (g/dl) (before surgery) 0.51 ± 0.41 0.51 ± 0.41 1.250 0.950 
HCT (before surgery) 0.07 ± 1.24 0.07 ± 1.25 0.620 0.517 
LVEF: Left ventricular ejection fraction; LVESD: Left ventricular end-systolic diameter; LVEDD: Left 
ventricular end-diastolic diameter; LAD: Left atrial diameter; ESR: Erythrocyte sedimentation rate; WBC: 
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Table 2. Distribution of absolute and relative frequency of demographic and clinical  
characteristics of patients in control and intervention groups 
Variable Control group Intervention group Total P
*
 
[n (%)] [n (%)] [n (%)] 
Gender Female 8 (26.7) 6 (20.0) 14 (23.3) 0.542 
Male 22 (73.3) 24 (80.0) 46 (76.7) 
HTN Yes 8 (26.7) 8 (26.7) 16 (26.7) > 0.999 
No 22 (73.3) 22 (73.3) 44 (73.3) 
History of smoking Yes 5 (16.7) 5 (16.7) 10 (16.7) > 0.999 
No 25 (83.3) 25 (83.3) 50 (83.3) 
History of MI Yes 5 (16.7) 5 (16.7) 10 (16.7) > 0.999 
No 25 (83.3) 25 (83.3) 50 (83.3) 
DM Yes 6 (20.0) 5 (17.2) 11 (18.6) 0.786
**
 
No 24 (82.8) 24 (80.0) 48 (81.3) 
Hypercholesterolemia Yes 2 (6.7) 2 (6.7) 4 (6.7) > 0.999 
No 28 (93.3) 28 (93.3) 56 (93.3) 
Taking beta blocker before surgery Yes 3 (10.0) 5 (16.7) 8 (13.3) 0.448 
No 27 (90.0) 25 (83.3) 52 (86.7) 
Taking statin before surgery Yes 2 (6.7) 2 (6.7) 4 (6.7) > 0.999 
No 28 (93.3) 28 (93.3) 56 (93.3) 
Taking nitrates before surgery Yes 12 (40.0) 8 (26.7) 20 (33.3) 0.410 
No 18 (60.0) 22 (73.3) 40 (66.7) 
* Chi-square test, ** Degree of freedom (df) = 1 
HTN: Hypertension; MI: Myocardial infarction; DM: Diabetes mellitus 
 
The last column of the table represents the 
results of independent chi-square test on the 
probability of a significant statistical difference 
between the variables mentioned in the control 
and intervention groups. The results indicated 
that there was no statistically significant 
difference between these indices in both of the 
groups and they were completely similar 
(Table 2). 
After demonstrating the similarity of 
quantitative and qualitative indices of clinical 
and paraclinical factors and demographic 
characteristics, at base and during the 
operation in both control and intervention 
groups, the role of oral vitamin C 
supplementation in the incidence of AF after 
CABG surgery will be explained. 
The results showed that the average length 
of stay in ICU in the control group was  
5.70 ± 0.41 days, and the average length of stay 
in ICU in the intervention group and after oral 
administration of vitamin C supplement was 
4.60 ± 0.34 days that means duration of 
hospitalization in ICU in intervention group 
was less. Also, the average length of stay in the 
hospital after operation (including the total 
length of stay in the ICU and the surgery 
ward) in the control group was 0.55 ± 0.46 
days, and in the intervention group was  
0.67 ± 5.40 days, which showed that the two 
groups did not have much difference.  
Discussion 
This study showed that oral intake of vitamin 
C supplement before and after open heart 
surgery reduced the incidence of AF after 
surgery. The results of this study indicated 
that oral intake of vitamin C supplement 
before and after this operation reduced 2 times 
the incidence of AF. In this clinical trial study 
that was performed on 60 patients in control 
and study groups (30 in each group), the 
incidence of AF in the control and intervention 
groups was 23.3% and 10.0%, respectively. 
In a similar clinical trial which was done by 
Borzak et al. on a total of 100 patients 
undergoing cardiovascular transplantation, the 
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incidence of AF has been studied.17 The results of 
this study are in line with their results. However, 
the incidence of AF in their study was lower 
than the present study, and in the intervention 
group, the incidence of AF decreased.  
Another study showed that the incidence of 
AF after open heart surgery following 
intravenous (IV) ascorbic acid was 61.2% in the 
control group and 54.47% in the intervention 
group. In this study, the incidence of AF after 
open heart surgery has been reported very 
high in control group (61.2%); this study has 
been done on a larger number of samples.18  
In the present study, it has been shown that 
the intake of oral vitamin C supplement, in 
addition to the effect on AF, reduces the length 
of stay of patients in the ICU. The results 
indicated that the average duration of stay in 
ICU in control group was 5.7 days, while in the 
intervention group and after oral 
administration of oral vitamin C supplement, 
it was 4.6 days. This means that taking vitamin 
C supplement in the intervention group 
reduces the duration of hospitalization in ICU. 
In a similar study, the duration of stay of 
patients with AF after surgery in the ICU was 
3.2 days and in patients with sinus rhythm, it 
was 3.2 days. This period of hospitalization in 
ICU in patients with AF is more than the 
results of the present study.12 Other study 
showed that duration of hospitalization in ICU 
was 2.7 days in patients with AF and 2 days in 
patients with sinus rhythm, which is consistent 
with the results obtained in this study.19  
In this study, although there was a 
significant difference in duration of stay of 
patients after surgery in both intervention and 
control groups, the difference, compared to 
other studies, was not much. The reason for 
this is that there was no difference between the 
length of stay of patients with AF who 
underwent CABG and those with other 
reasons because these patients did not undergo 
continuous cardiac monitoring after 
transferring to general ward. They were 
checked daily by ECG. In many cases, AF 
occurs in a very short time that doctors or 
nurses do not notice it; therefore, patients are 
not under certain treatment to control it. 
However, most of the cases of AF are  




The results of this study, which are in line with 
extensive studies in order to achieve an 
effective drug or surgical method, and more 
importantly, an effective prophylactic method 
for the prevention of post-cardiac surgery 
arrhythmias, specifically AF, have been 
promising a new solution to prevent and treat 
this arrhythmia. These results require more 
trials to fully understand its effect and long-
term adverse effects. The study's limitations 
included the need for patients’ follow-up and 
timely intervention in administration of 
vitamin C in patients with postoperative AF.  
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